Company: MLTX
Filing Date: 2025-11-05
Form Type: 8-K
Source: 0001821586-25-000021
Chunk: 0

Company: MoonLake Immunotherapeutics
Filing Date: 2025-11-05
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02. Results of Operations and Financial Condition.

On November 5, 2025, MoonLake Immunotherapeutics (the “ Company”) issued a press release announcing its financial results for the quarter ended September 30, 2025. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

This Item 2.02 and the press release attached hereto as Exhibit 99.1, insofar as they disclose information regarding the Company’s results of operation and financial condition for the quarter ended September 30, 2025, are being furnished to the U. S. Securities and Exchange Commission (“ SEC”).